ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2023

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis.

Oliver J McElvaney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.